Idiopathic Pulmonary Fibrosis Solutions Overview

Date Published:

Signant’s comprehensive clinical research solutions and services help your idiopathic pulmonary fibrosis (IPF) studies succeed by improving endpoint data quality, reducing participant burdens, and increasing operational efficiencies.

Our solutions help researchers:

  • Conduct the six-minute walk test consistently and accurately
  • Collect high quality data from L-IPF, PGI-C/S, and other assessments
  • Simplify complexities inherent in global studies
  • Replace inefficient and imprecise paper processes

Learn how by downloading the brochure.